ArticlePloS one2026
Persistent proteinuria among a cohort of Nigerian children with sickle cell anaemia.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPersistent proteinuria is an early and modifiable marker of kidney damage. Although Nigeria has the highest burden of sickle cell anaemia (SCA) globally, the prevalence of proteinuria is unknown largely because many of the studies only determined proteinuria in a single urine sample or used less sensitive methods, such as dipstick. Unlike dipstick screening, quantitative urine protein-creatinine ratio allows more accurate detection of low-grade proteinuria.
objectivesTo determine the prevalence and determinants of persistent proteinuria among children with SCA.
methodsChildren with SCA and age and sex-matched controls attending a publicly funded hospital in central Nigeria were consecutively enrolled. Proteinuria was determined at the first visit using the spot urine protein creatinine ratio and repeated at least 3 months afterwards for those with proteinuria. In addition, serum creatinine, full blood count, and fetal hemoglobin were determined at the first visit. Persistent proteinuria was defined as a urine protein-to-creatinine ratio ≥0.2 at both visits over a follow-up period of at least 3 months. Participants were classified based on the presence or absence of persistent proteinuria, and baseline characteristics were compared using within-group distributions for categorical variables with appropriate statistical tests.
resultsOne hundred and forty-nine children, each with SCA and controls, were enrolled, respectively. The median (IQR) age of the study participants was 9.0 (6.0) years for both groups, with 65% being males. Persistent proteinuria occurred in 35 (23.5%) children with SCA versus 4 (2.7%) controls (p-value < 0.01). Children with persistent proteinuria had a lower level of fetal hemoglobin. (adjusted OR 0.583, 95% C.I 0.473-0.719).
conclusionAbout a quarter of children with SCA had persistent proteinuria, an early and modifiable marker of chronic kidney disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.